Search results

1. The role of simultaneous and individual modulation of μ-opioid, sigma-1 and histamine H3 receptors as a new therapeutic …

Principal investigator: dr Katarzyna Anna Szczepańska

Instytut Farmakologii PAN

Call: OPUS 23, Panel: NZ7

2. Chronic pain in obesity: from cellular mechanisms to new strategies for targeted therapy.

Principal investigator: dr Anna Piotrowska-Murzyn

Instytut Farmakologii PAN

Call: SONATA 17, Panel: NZ5

3. Development of optimization methods for dose selection of analgesic drugs used as a combination drug therapy in neuropat…

Principal investigator: dr hab. Kinga Sałat

Uniwersytet Jagielloński- Collegium Medicum, Uniwersytet Jagielloński - Collegium Medicum; Wydział Farmaceutyczny

Call: OPUS 9, Panel: NZ7

4. Opioid-induced analgesia and hyperalgesia in neuropathic pain - mechanisms and druggable targets

Principal investigator: prof. Barbara Elżbieta Przewłocka

Instytut Farmakologii PAN

Call: OPUS 15, Panel: NZ7

5. The role of kynurenine pathway in neurophatic pain in view of innovative treatment approaches

Principal investigator: dr Ewelina Joanna Rojewska

Instytut Farmakologii PAN

Call: SONATA 9, Panel: NZ4

6. New strategies in the pharmacotherapy of neuropathic pain based on modulation of the chemokine system and its influence …

Principal investigator: prof. Joanna Gabriela Mika

Instytut Farmakologii PAN

Call: OPUS 22, Panel: NZ7

7. New 3-methoxypropanamide derivatives in search of effective substances for the treatment of neurological diseases - epil…

Principal investigator: Marcin Konrad Jakubiec

Uniwersytet Jagielloński, Collegium Medicum

Call: PRELUDIUM 20, Panel: NZ7

8. Dual histamine H3 and sigma-1 receptor ligands as novel pharmacological tools in the treatment of central nervous system…

Principal investigator: dr Katarzyna Anna Szczepańska

Instytut Farmakologii PAN

Call: SONATINA 4, Panel: NZ7

9. Pharmacological modulation of histamine H3 and H4 receptors - a new perspective in the treatment of neuropathic pain

Principal investigator: dr Katarzyna Popiołek-Barczyk

Instytut Farmakologii PAN

Call: SONATA 15, Panel: NZ7

10. Determination of the mechanisms and potential targets for neuropathic pain therapy by investigating pharmacological inte…

Principal investigator: Anna Piotrowska-Murzyn

Instytut Farmakologii PAN

Call: PRELUDIUM 12, Panel: NZ7

11. Search for new targets for an effective therapy of neuropathic pain and enhancement of opioids effects basing on the exa…

Principal investigator: prof. Joanna Gabriela Mika

Instytut Farmakologii PAN

Call: OPUS 11, Panel: NZ4

12. Neuronal and nonneuronal mechanisms of Bont/A effects in neuropathic pain development - behavioral and biochemical studi…

Principal investigator: dr hab. Joanna Gabriela Mika

Instytut Farmakologii PAN

Call: HARMONIA 5, Panel: NZ4

13. Exploring new drug targets for efficacious therapy of neuropathic pain basing on the assessment and modulation of neuroi…

Principal investigator: dr hab. Joanna Gabriela Mika

Instytut Farmakologii PAN

Call: OPUS 2, Panel: NZ4

14. New strategies in neuropathic pain pharmacotherapy based on the modulation of the functions of chemokine receptors CCR2 …

Principal investigator: dr Klaudia Kwiatkowski

Instytut Farmakologii PAN

Call: PRELUDIUM 15, Panel: NZ7

15. Activation of endogenous pronociceptive mechanisms of opioid system as an important factors in the development of neurop…

Principal investigator: prof. Barbara Elżbieta Przewłocka

Instytut Farmakologii PAN

Call: MAESTRO 3, Panel: NZ4

16. Understanding the contribution of immunoproteasome activation to the neuropathic pain development.

Principal investigator: dr Natalia Eleonora Małek-Chudzik

Politechnika Wrocławska

Call: OPUS 25, Panel: NZ7

17. Decoding the novel role of the histamine H3 receptor in opioid-induced analgesia and hyperalgesia: studies toward innova…

Principal investigator: dr Katarzyna Popiołek-Barczyk

Instytut Farmakologii PAN

Call: OPUS 28, Panel: NZ7

18. Multifunctional ligands - TRPA1 channel antagonists and phosphodiesterases inhibitors as a new approach for the treatmen…

Principal investigator: prof. Grażyna Chłoń-Rzepa

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

Call: OPUS 15, Panel: NZ7

19. Dual-Target Compounds Modulating EAAT2 and Kv7.2/3 Channels: A Rational Strategy Toward Novel Antiseizure and Antinocice…

Principal investigator: dr Michał Andrzej Abram

Uniwersytet Jagielloński

Call: OPUS 29, Panel: NZ7

20. Selective inhibitors of γ-aminobutyric acid (GABA) transporter subtype 3 (GAT3) as a new pharmacological tools and a cha…

Principal investigator: dr Dawid Marcin Panek

Uniwersytet Jagielloński, Collegium Medicum

Call: OPUS 21, Panel: NZ7

21. Novel hybrid compounds derived from pyrrolidine-2,5-dione or imidazolidine-2,4-dione scaffold and their effect on centra…

Principal investigator: dr hab. Krzysztof Tomasz Kamiński

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

Call: OPUS 13, Panel: NZ7

22. Functionalized amino acids - inibitors of GABA uptake with antianalgetic activity

Principal investigator: dr Paula Magdalena Zaręba

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

Call: OPUS 8, Panel: NZ7

23. Synthesis, physicochemical and pharmacological properties of new amide derivatives of 3,3-disubstituted pyrrolidine-2,5-…

Principal investigator: prof. Jolanta Maria Obniska

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

Call: OPUS 6, Panel: NZ7

Projects search